AprilBio Co.,Ltd. (KOSDAQ:397030)

Market Cap	997.43B +157.7%
Revenue (ttm)	725.35M -97.6%
Net Income	-10.12B
EPS	-444.25
Shares Out	23.41M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	642,703
Open	40,000
Previous Close	38,500
Day's Range	37,200 - 41,750
52-Week Range	16,160 - 76,700
Beta	1.45
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About AprilBio

AprilBio Co.,Ltd. develops long-acting type biobetter and antibody biologics. The company develops antibody drugs, double antibodies, long-acting antibody drugs, long-acting protein drugs, and ADC-applied antibodies. It is developing various products for use in the treatment of rare diseases, cancer, male infertility, autoimmune and inflammatory diseases. The company was founded in 2013 and is headquartered in Chuncheon-si, South Korea.

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2013
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 397030

Financial Performance

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Jun 29, 2026

Data Sources Report a data error